| 000 | 01813cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030915.0 | ||
| 008 | 131217s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.12.02.M.Sc.2012.He.M | ||
| 100 | 0 | _aHeba Allah Mohamed Mohamed Nour Aldeen | |
| 245 | 1 | 0 |
_aMolecular markers predicting the efficacy of interferon - based therapies in patients with chronic hepatitis C / _cHeba Allah Mohamed Mohamed Nour Aldeen ; Supervised Amr Saad Mohamed , Olfat G. Shaker , Gamal Eldin Essmat |
| 246 | 1 | 5 | _aالعلامات الجزئية التى تنبئ بفاعلية العلاج المعتمد على الانترفيرون الخاص بمرضى فيروس التهاب الكبد الوبائى سى |
| 260 |
_aCairo : _bHeba Allah Mohamed Mohamed Nour Aldeen , _c2012 |
||
| 300 |
_a157 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry | ||
| 520 | _aAim of the study : To detect the SNPs (single nucleotide polymorphisms) in the promoter region (-88,-123) of the MxA in the blood of chronic liver disease patients under treatment with interferon . Also to investigate the association between these polymorphisms and the response to IFN-Ü therapy in HCV - infected Egyptian patients | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHepatitis C virus | |
| 653 | 4 | _aInterferon | |
| 653 | 4 | _aPegylated interferon | |
| 700 | 0 |
_aAmr Saad Mohamed , _eSupervisor |
|
| 700 | 0 |
_aGamal Eldin Essmat , _eSupervisor |
|
| 700 | 0 |
_aOlfat Gamel Shaker , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c44473 _d44473 |
||